期刊
FRONTIERS IN PHARMACOLOGY
卷 13, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.1050928
关键词
platinum compounds; side effects; resistance; nanocarriers; combination chemotherapy
资金
- Natural Science Foundation of Jiangsu Province
- Jiangsu Planned Projects for Postdoctoral Research Funds
- [BK20170445]
- [2021K271B]
This review presents recent advancements in nanocarriers containing platinum compounds for combination cancer chemotherapy. These nanocarriers have the potential to address side effects and resistance associated with platinum-based drugs.
Platinum compounds-based drugs are used widely in the clinic for the treatment of many types of cancer. However, serious undesirable side effects and intrinsic or acquired resistance limit their successful clinic use. Nanocarrier-based combination chemotherapy is considered to be an effective strategy to resolve these challenges. This review introduces the recent advance in nanocarriers containing platinum compounds for combination cancer chemotherapy, including liposomes, polymer nanoparticles, polymer micelles, mesoporous silica nanoparticles, carbon nanohors, polymer-caged nanobins, carbon nanotube, nanostructured lipid carriers, solid lipid nanoparticles, and multilayered fiber mats in detail.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据